Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers
Tobias Brummer, Muthuraman Muthuraman, Falk Steffen, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Cognitive Impairment in Multiple Sclerosis: An Update on Assessment and Management
Emilio Portaccio, Maria Pia Amato
NeuroSci (2022) Vol. 3, Iss. 4, pp. 667-676
Open Access | Times Cited: 37
Toward identifying key mechanisms of progression in multiple sclerosis
Leila Husseini, Anastasia Geladaris, Martin S. Weber
Trends in Neurosciences (2023) Vol. 47, Iss. 1, pp. 58-70
Open Access | Times Cited: 17
Artificial Intelligence and Multiple Sclerosis
Moein Amin, Eloy Martínez‐Heras, Daniel Ontaneda, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 8, pp. 233-243
Open Access | Times Cited: 8
Molecular biomarkers and cognitive impairment in multiple sclerosis: State of the field, limitations, and future direction – A systematic review and meta-analysis
Tom-D. Rademacher, Sven G. Meuth, Heinz Wiendl, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105035-105035
Closed Access | Times Cited: 16
Neuroimaging and neuromodulation of invisible symptoms in multiple sclerosis
Samar S. Ayache, Moussa A. Chalah
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury
Martin Schaller, Michelle Maiworm, Jan Hendrik Schäfer, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3512-3526
Open Access | Times Cited: 5
A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort
Maureen van Dam, Brigit A. de Jong, Eline A.J. Willemse, et al.
Journal of Neurology (2023) Vol. 270, Iss. 8, pp. 3851-3861
Open Access | Times Cited: 11
The Blood Concentration of Metallic Nanoparticles Is Related to Cognitive Performance in People with Multiple Sclerosis: An Exploratory Analysis
Marcela de Oliveira, Felipe Balistieri Santinelli, Paulo Noronha Lisboa‐Filho, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1819-1819
Open Access | Times Cited: 11
A Radiomic “Warning Sign” of Progression on Brain MRI in Individuals with MS
Brendan S. Kelly, Prateek Mathur, Gerard McGuinness, et al.
American Journal of Neuroradiology (2024) Vol. 45, Iss. 2, pp. 236-243
Open Access | Times Cited: 4
Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 8, pp. 871-899
Closed Access | Times Cited: 4
Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis
Monokesh Kumer Sen, Md Jakir Hossain, David A. Mahns, et al.
Journal of Neurology (2022) Vol. 270, Iss. 4, pp. 1908-1930
Closed Access | Times Cited: 18
Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span
Julia Elmers, Lorenza S. Colzato, Katja Akgün, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102037-102037
Closed Access | Times Cited: 10
Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis
Vinzenz Fleischer, Tobias Brummer, Muthuraman Muthuraman, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing–Remitting Multiple Sclerosis with Cognitive Impairment
José Manuel García‐Domínguez, Jorge Mauriño, José Meca-Lallana, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 69-69
Open Access
Motor symptoms at onset and manual dexterity predict cognitive impairment in drug-naïve individuals with multiple sclerosis
Eman M. Khedr, M. M. A. Hassan, Mohamed Yosri Ezzeldeen, et al.
Journal of Neuroimmunology (2025) Vol. 401, pp. 578571-578571
Closed Access
Cognitive Impairment in Newly Diagnosed Patients with Multiple Sclerosis: A Systematic Review of Related Molecular Biomarkers and a Meta-Analysis of Associated Demographic and Disease-Related Characteristics
Konstantina Stavrogianni, Vasileios Giannopapas, Dimitrios K. Kitsos, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2630-2630
Open Access
Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review
Hibba Yousef, Brigitta Malagurski Tortei, Filippo Castiglione
Journal of Neurology (2024)
Open Access | Times Cited: 3
The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy
Andrew R. Pachner
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2099-2099
Open Access | Times Cited: 12
Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
Angelo Ghezzi, Rinze F. Neuteboom
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1867-1881
Open Access | Times Cited: 7
Neuroimaging Technology in Exercise Neurorehabilitation Research in Persons with MS: A Scoping Review
Brian M. Sandroff, Caroline M. Rafizadeh, Robert W. Motl
Sensors (2023) Vol. 23, Iss. 9, pp. 4530-4530
Open Access | Times Cited: 6
Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: A 5-year longitudinal study
Oun Al-iedani, Stasson Lea, Abdulaziz M Alshehri, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 81, pp. 105379-105379
Closed Access | Times Cited: 6
Serum neurofilament light chain is more strongly associated with T2 lesion volume than with number of T2 lesions in patients with multiple sclerosis
Katharina J. Wenger, Maya Hoelter, Yavor Yalachkov, et al.
European Journal of Radiology (2023) Vol. 166, pp. 111019-111019
Closed Access | Times Cited: 5
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis
Georgina Arrambide, Manuel Comabella, Carmen Tur
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Molecular biomarkers and cognitive impairment in multiple sclerosis: A review
Sara Esmaeili, Ahmed Z. Obeidat, Aram Zabeti
Biomarkers in Neuropsychiatry (2023) Vol. 9, pp. 100077-100077
Open Access | Times Cited: 3
Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammation
Tobias Brummer, Miriam Schillner, Falk Steffen, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top